Dr. Regina Rabinovich Succeeds Dr. Axel Hoos as Sabin Vaccine Institute Board Chair, Drs. Norman Baylor and JoAnn Suzich Join the Board

The Sabin Vaccine Institute (Sabin) is pleased to announce the Board of Trustees has unanimously elected Regina Rabinovich, MD, MPH, as board chair and elected two new trustees, Dr. Norman Baylor and Dr. JoAnn Suzich, to strengthen the organization’s leadership in global immunization and vaccine research and development.

This blog post is part of Sabin’s Vaccine IQ: Intro to Vaccine Research & Development series, in which experts from Sabin’s Vaccine R&D team give an introduction to how vaccines are made, explaining the stages of research, development and testing vaccine candidates must go th

This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and public health in the midst of the COVID-19 pandemic.

In the era of COVID-19, infectious diseases and vaccines are in the daily headlines and on everyone's mind. But COVID-19 is far from being the only infectious disease that has sent scientists scrambling for a cure.

This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and public health in the midst of the COVID-19 pandemic.

Skoll Foundation Funds Sabin Vaccine Institute, Dalberg and JSI Research & Training Institute, Inc. to Establish COVID-19 Vaccine Equity Project

As COVID-19 vaccine developers generate clinical evidence of safety and effectiveness needed for vaccine approval, this project will help prepare for the efficient and equitable distribution of vaccines globally by ensuring that national immunization programs have the resources and health systems in place to achieve sustainable global protection from COVID-19 by 2022 and strengthen capacity for vaccination across the life span.

On September 8, 2020, Bruce Gellin, MD, MPH, president of Global Immunization at the Sabin Vaccine Institute (Sabin), participated in a panel titled, “The Science of Vaccine Confidence,” as part of the 2020 Virtual National Health Research Forum hosted by

This blog post is part of Sabin’s Vaccine IQ: Intro to Vaccine Research & Development series, in which experts from Sabin’s Vaccine R&D team give an introduction to how vaccines are made, explaining the stages of research, development and testing vaccine candidates must go th

Pages